On Demand Webinars
CCAB: Addressing the risk of microbial impurities in Biologics and certain Advanced Therapy Medicinal Products (ATMPs)
Presented by Dr Friedrich von Wintzingerode, QC Lead iNeST (individual Neoepitope Specific Therapy), Roche and Nahuel Paolini, PhD, Sanquin Reagents
28th March 2022
CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy
Presented by Sarah Thomas, Vice President of Quality at REGENXBIO Inc. and Joanna Zmurko, NGS specialist at PathoQuest
23rd March 2022
An impurity detected in a stability study: Did we miss anything in our E&L risk assessment?
Presented by Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe
15th March 2022
Holistic Approach to the Industry 4.0 Investment Breaking Down the Fences Between R&D & Manufacturing
Presented by Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning at The Janssen Pharmaceutical Companies of Johnson & Johnson and Shilpa Nargund, Director at Insilico Biotechnology Pte. Ltd., Singapore
14th March 2022
Regulatory Strategies For Rapid Sterility Testing of Gene and Cell Therapy Products
Presented by Dr. Michael J. Miller, President of Microbiology Consultants, LLC and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
07th March 2022
Overcoming Antibody-Drug Conjugate (ADC) Process Development & Manufacturing Challenges
Presented by Dr. Jimmy Li, CEO of WuXi XDC (a WuXi Biologics subsidiary)
23rd February 2022
In-line monitoring of surfactant clearance in viral vaccine downstream processing
Presented by Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur
15th February 2022
We Are Going Back to the Future with Rapid Methods.
Presented by Dr. Michael J. Miller, President of Microbiology Consultants, LLC and Félix Montero-Julian, Scientific Director at bioMérieux
14th February 2022
Handling mutagenic extractable and leachable compounds released from devices
Presented by Ron Brown, Toxicologist at Risk Science Consortium and Piet Christieans, PhD, Scientific Director at Nelson Labs
10th February 2022
Applications of industry 4.0 concepts in continuous pharmaceutical tablet manufacturing process
Presented by Dr Ravendra Singh, Research Faculty at C-SOPS, Department of Chemical and Biochemical Engineering, Rutgers University, NJ, USA
27th January 2022
